COVID-19 vaccinations not only reduce the likelihood of catching the disease, but also the risk of related clot and heart complications, according to a new observational study published in the journal Heart.
"Our analyses showed a substantial reduction of risk (42--82%) for thromboembolic and cardiac events in the acute phase of COVID-19 associated with vaccination," stated the researchers.
"Reduced risk in vaccinated people lasted for up to one year for post-COVID-19 venous thromboembolism, arterial thrombosis/thromboembolism and heart failure, but not clearly for other complications."
However, the authors of the study noted that further research into the possible waning of the protective effects of the vaccination over time and the impact of boosters is required.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 24
